Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Sales | 225.20 | 241.36 | 204.67 | 182.04 | 153.05 |
| Operating profit | 33.91 | 41.98 | 37.30 | 26.76 | 22.71 |
| Interest | 0.23 | 0.27 | 0.23 | 0.26 | 0.66 |
| Gross profit | 45.87 | 43.03 | 53.00 | 59.12 | 26.35 |
| EPS (Rs) | 0.73 | 0.56 | 0.69 | 0.98 | 0.39 |
Quarterly
results in details
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Other income | 12.19 | 1.33 | 15.93 | 32.62 | 4.30 |
| Stock adjustment | -2.13 | -1.46 | -5.90 | 2.25 | -7.38 |
| Raw material | 104.36 | 117.16 | 102.83 | 82.80 | 85.36 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 21.56 | 20.47 | 18.23 | 16.93 | 15.42 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 67.50 | 63.22 | 52.21 | 53.32 | 36.94 |
| Provisions made | - | - | - | - | - |
| Depreciation | 7.47 | 8.43 | 8.50 | 4.72 | 3.51 |
| Taxation | 5.41 | 9.31 | 13.21 | 10.20 | 5.04 |
| Net profit / loss | 32.99 | 25.29 | 31.29 | 44.19 | 17.81 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 45.32 | 45.32 | 45.32 | 45.32 | 45.32 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 15.06 | 17.39 | 18.22 | 14.70 | 14.84 |
| GPM (%) | 19.32 | 17.73 | 24.02 | 27.54 | 16.75 |
| NPM (%) | 13.90 | 10.42 | 14.18 | 20.59 | 11.32 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis